Overview
This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
Description
The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor:
- immunologic assays/flow cytometry
- tumor progression/regression
- genomic studies
- proteomic studies
- others germane to the advancement of CTCL treatment
Eligibility
Inclusion Criteria:
- 18 or older
- able and willing to provide informed consent
- diagnosed with CTCL
- diagnosed with either atopic dermatitis or eczema
Exclusion Criteria:
- Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record